Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555) Reply

Author(s):
Dijk, E.H.C. van (0000-0002-6351-7942); Fauser, S.; Breukink, M.B.; Blanco-Garavito, R.; Groenewoud, J.M.M.; Keunen, J.E.E.; Peters, P.J.H.; Dijkman, G.; Souied, E.H.; MacLaren, R.E.; Querques, G.; Downes, S.M.; Hoyng, C.B.; Boon, C.J.F.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-04-30
Language
English
Is part of
Ophthalmology: Journal of The American Academy of Ophthalmology (2019), Vol. 126, no. 4, p. E30-E31
hdl
1887/121078